Legend Biotech Corp ADR

24 de ago. de 2026, 23:01 UTC

Legend Biotech Corp shares are higher in after-market trading, continuing a strong upward trend since Monday's close. The stock remains above its 20-day moving average.

21 de ago. de 2026, 23:01 UTC

Legend Biotech Corp shares are higher in after-market trading, maintaining a position near the upper end of their one-month trading range.

20 de ago. de 2026, 23:46 UTC

Legend Biotech Corp. shares are trading higher in after-market hours, diverging from broader market pressures amid rising crude oil prices and geopolitical tensions.

19 de ago. de 2026, 23:01 UTC

Legend Biotech Corp shares are higher in after-market trading, showing notable strength and exceeding the 20-day moving average. No specific news was identified.

18 de ago. de 2026, 20:03 UTC

Legend Biotech Corp shares are higher today, buoyed by strong investor sentiment and analyst confidence in significant upside potential for the stock.

14 de ago. de 2026, 19:36 UTC

Shares of Legend Biotech Corp are trading higher, though fluctuations have been routine during the session. The stock remains below its 20-day moving average.

13 de ago. de 2026, 23:21 UTC

Legend Biotech Corp shares are higher in after-market hours, gaining traction following notable trading activity after Thursday's close. No specific news was identified.

12 de ago. de 2026, 23:16 UTC

Legend Biotech Corp. shares are higher in after-market hours, reflecting positive market conditions amid a Consumer Price Index report that met forecasts.

11 de ago. de 2026, 23:46 UTC

Shares of Legend Biotech Corp are higher in after-market hours, maintaining a position above the 20-day moving average amid stable trading conditions.

10 de ago. de 2026, 23:06 UTC

Shares of Legend Biotech are higher in after-market trading, settling above Monday's close despite mixed market sentiment and geopolitical tensions.

7 de ago. de 2026, 23:46 UTC

Shares of Legend Biotech Corp traded higher in after-market hours, amid a broader market context of a declining unemployment rate.

6 de ago. de 2026, 20:06 UTC

Legend Biotech Corp shares are higher today, reflecting a shift from recent trends. No specific company news was identified to explain this movement.

4 de ago. de 2026, 19:36 UTC

Legend Biotech Corp shares are higher today, recovering from an earlier low. Positive momentum persists despite a decline in U.S. core factory orders.

3 de ago. de 2026, 22:01 UTC

Shares of Legend Biotech Corp are higher in after-market trading, reflecting gains since Monday's close amid broader market advances in tech and oil-sensitive sectors.

31 de jul. de 2026, 23:56 UTC

Shares of Legend Biotech Corp. are higher in after-market trading, despite a slight decline earlier in the session and broader market weakness.

30 de jul. de 2026, 22:41 UTC

Shares of Legend Biotech Corp are trading lower in after-market hours, continuing a trend of unusual weakness since Thursday's close.

29 de jul. de 2026, 19:27 UTC

Legend Biotech Corp shares are lower, extending a four-session decline. Raymond James projects a 12-month price target range of $58 to $86.

28 de jul. de 2026, 22:56 UTC

Shares of Legend Biotech Corp are trading higher in after-market hours, despite no specific news identified. The broader market showed gains earlier in the day.

27 de jul. de 2026, 23:16 UTC

Legend Biotech Corp shares are higher in after-market hours, having briefly reached a session high. The price remains below its 20-day moving average.

24 de jul. de 2026, 19:16 UTC

UBS downgraded Legend Biotech Corp to Neutral and cut its price target to $28, contributing to a decline in shares during Friday's session.

22 de jul. de 2026, 18:31 UTC

Legend Biotech Corp shares are lower today amid broader market weakness and rising geopolitical tensions, despite an earlier peak during the session.

21 de jul. de 2026, 16:46 UTC

Legend Biotech Corp. shares are higher today, reaching a session peak amid rising crude oil prices, despite trading below its 20-day moving average.

20 de jul. de 2026, 19:01 UTC

Legend Biotech Corp is trading higher during Monday's session, rebounding from an earlier low and showing strength after a week of declines.